Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Heart Transplantation | 15 | 2021 | 1293 | 2.31 | Why? |
| Heart-Assist Devices | 11 | 2021 | 812 | 1.51 | Why? |
| Heart Failure | 15 | 2021 | 6638 | 1.26 | Why? |
| Cardiography, Impedance | 1 | 2019 | 16 | 0.83 | Why? |
| Transforming Growth Factor beta1 | 1 | 2017 | 204 | 0.62 | Why? |
| Cardiomyopathy, Dilated | 2 | 2018 | 251 | 0.58 | Why? |
| Ventricular Remodeling | 1 | 2018 | 349 | 0.54 | Why? |
| Shock, Cardiogenic | 2 | 2020 | 700 | 0.53 | Why? |
| Ventricular Function, Right | 2 | 2019 | 388 | 0.49 | Why? |
| Graft Rejection | 2 | 2020 | 1766 | 0.47 | Why? |
| Tissue Donors | 2 | 2018 | 1679 | 0.44 | Why? |
| Donor Selection | 1 | 2017 | 804 | 0.42 | Why? |
| Coronary Artery Disease | 3 | 2019 | 2570 | 0.38 | Why? |
| Recovery of Function | 2 | 2019 | 2461 | 0.36 | Why? |
| Ventricular Function, Left | 3 | 2019 | 1555 | 0.34 | Why? |
| Tissue and Organ Procurement | 1 | 2017 | 1277 | 0.32 | Why? |
| Transplantation, Homologous | 2 | 2020 | 757 | 0.31 | Why? |
| Resource Allocation | 1 | 2017 | 1771 | 0.30 | Why? |
| Immunosuppressive Agents | 2 | 2021 | 6331 | 0.29 | Why? |
| Hepatitis B Core Antigens | 1 | 2005 | 76 | 0.28 | Why? |
| Hepatitis B Antibodies | 1 | 2005 | 142 | 0.27 | Why? |
| Lung Transplantation | 1 | 2015 | 1554 | 0.26 | Why? |
| Myocardium | 3 | 2020 | 2323 | 0.25 | Why? |
| Health Care Rationing | 1 | 2017 | 2558 | 0.24 | Why? |
| Allografts | 4 | 2018 | 761 | 0.24 | Why? |
| Lung Diseases | 1 | 2015 | 2361 | 0.22 | Why? |
| Exercise Test | 2 | 2019 | 911 | 0.21 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.20 | Why? |
| Ventricular Dysfunction | 1 | 2020 | 150 | 0.19 | Why? |
| Angina Pectoris, Variant | 1 | 2018 | 3 | 0.19 | Why? |
| Thrombospondin 1 | 1 | 2017 | 29 | 0.18 | Why? |
| Cardiac Output | 1 | 2019 | 183 | 0.18 | Why? |
| Vasoplegia | 1 | 2018 | 27 | 0.18 | Why? |
| Primary Graft Dysfunction | 1 | 2017 | 44 | 0.17 | Why? |
| Antibodies, Anti-Idiotypic | 1 | 2017 | 93 | 0.17 | Why? |
| Postoperative Complications | 4 | 2019 | 5861 | 0.16 | Why? |
| Cardiopulmonary Bypass | 1 | 2018 | 158 | 0.16 | Why? |
| Benzhydryl Compounds | 1 | 2019 | 240 | 0.15 | Why? |
| Papillary Muscles | 1 | 2014 | 8 | 0.14 | Why? |
| Coronary Angiography | 3 | 2020 | 2275 | 0.14 | Why? |
| Glucosides | 1 | 2019 | 359 | 0.14 | Why? |
| Coronary Vessels | 2 | 2018 | 914 | 0.13 | Why? |
| Exercise Tolerance | 2 | 2019 | 634 | 0.13 | Why? |
| Coronary Artery Bypass | 2 | 2019 | 629 | 0.13 | Why? |
| Prosthesis Implantation | 1 | 2016 | 261 | 0.13 | Why? |
| Platelet Activation | 1 | 2017 | 660 | 0.13 | Why? |
| Retinol-Binding Proteins, Plasma | 1 | 2012 | 4 | 0.13 | Why? |
| Metabolic Syndrome | 1 | 2020 | 810 | 0.12 | Why? |
| Cardiovascular Agents | 1 | 2019 | 663 | 0.12 | Why? |
| Drug-Eluting Stents | 1 | 2019 | 562 | 0.12 | Why? |
| Amyloidosis | 1 | 2014 | 178 | 0.11 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.11 | Why? |
| Myocytes, Cardiac | 1 | 2018 | 804 | 0.11 | Why? |
| Male | 24 | 2021 | 367725 | 0.11 | Why? |
| Exosomes | 1 | 2017 | 567 | 0.11 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.11 | Why? |
| Heart | 1 | 2020 | 1791 | 0.11 | Why? |
| Robotic Surgical Procedures | 1 | 2019 | 787 | 0.11 | Why? |
| Tachycardia, Ventricular | 1 | 2014 | 251 | 0.11 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.10 | Why? |
| Electrocardiography | 3 | 2020 | 3957 | 0.10 | Why? |
| Retrospective Studies | 12 | 2021 | 105322 | 0.10 | Why? |
| Treatment Outcome | 8 | 2021 | 51732 | 0.10 | Why? |
| Heart Ventricles | 2 | 2021 | 1139 | 0.10 | Why? |
| Defibrillators, Implantable | 1 | 2016 | 624 | 0.10 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.10 | Why? |
| Female | 23 | 2021 | 380317 | 0.10 | Why? |
| Catheter Ablation | 1 | 2014 | 438 | 0.09 | Why? |
| Humans | 33 | 2021 | 930598 | 0.09 | Why? |
| New York | 3 | 2021 | 2488 | 0.09 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.09 | Why? |
| Propensity Score | 1 | 2016 | 2690 | 0.09 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.09 | Why? |
| Ventricular Dysfunction, Right | 1 | 2015 | 639 | 0.09 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.08 | Why? |
| Adult | 14 | 2020 | 244371 | 0.08 | Why? |
| B-Lymphocytes | 2 | 2017 | 4418 | 0.07 | Why? |
| New York City | 4 | 2020 | 7432 | 0.07 | Why? |
| Stroke Volume | 1 | 2015 | 2153 | 0.07 | Why? |
| Aged | 13 | 2021 | 215776 | 0.07 | Why? |
| Graft Occlusion, Vascular | 1 | 2005 | 105 | 0.07 | Why? |
| Anxiety Disorders | 1 | 2017 | 2290 | 0.07 | Why? |
| Myocardial Infarction | 1 | 2020 | 3361 | 0.07 | Why? |
| Coronary Circulation | 1 | 2005 | 188 | 0.07 | Why? |
| Hemodynamics | 1 | 2012 | 1562 | 0.07 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.06 | Why? |
| Lamivudine | 1 | 2005 | 210 | 0.06 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2005 | 309 | 0.06 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.06 | Why? |
| Atrial Fibrillation | 1 | 2016 | 2320 | 0.06 | Why? |
| Transplant Recipients | 1 | 2017 | 4982 | 0.05 | Why? |
| Registries | 2 | 2021 | 12327 | 0.05 | Why? |
| Quality of Life | 2 | 2019 | 9820 | 0.05 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.05 | Why? |
| Hospitalization | 5 | 2021 | 54280 | 0.05 | Why? |
| Adaptation, Psychological | 1 | 2017 | 4996 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Ultrasonography | 1 | 2015 | 4409 | 0.05 | Why? |
| Exercise | 1 | 2019 | 6771 | 0.05 | Why? |
| Incidence | 5 | 2020 | 25622 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Hepatitis B, Chronic | 1 | 2005 | 616 | 0.04 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.04 | Why? |
| Cardiomyopathy, Hypertrophic | 1 | 2019 | 193 | 0.04 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.04 | Why? |
| Heart Diseases | 1 | 2014 | 3503 | 0.04 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.04 | Why? |
| Reoperation | 1 | 2019 | 544 | 0.04 | Why? |
| Walk Test | 1 | 2019 | 461 | 0.04 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.04 | Why? |
| Angiography | 1 | 2017 | 301 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.03 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.03 | Why? |
| Plasma Cells | 1 | 2017 | 464 | 0.03 | Why? |
| Echocardiography | 2 | 2020 | 3661 | 0.03 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Patients | 1 | 2020 | 1167 | 0.03 | Why? |
| Survival Analysis | 1 | 2005 | 7592 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Time Factors | 3 | 2019 | 31397 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 7868 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Double-Blind Method | 1 | 2019 | 5988 | 0.02 | Why? |
| Fasting | 1 | 2012 | 555 | 0.02 | Why? |
| Electronic Health Records | 1 | 2020 | 3492 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Vascular Patency | 1 | 2005 | 96 | 0.02 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.02 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.02 | Why? |
| Regional Blood Flow | 1 | 2005 | 172 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Insulin | 1 | 2012 | 1316 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2015 | 6543 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.01 | Why? |
| Oxygen Consumption | 1 | 2005 | 711 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Positron-Emission Tomography | 1 | 2005 | 802 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Blood Glucose | 1 | 2012 | 3642 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Prospective Studies | 1 | 2019 | 43301 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
Mancini's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(158)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(152)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_